Zentalis Pharmaceuticals Income Statement (2022-2025) | ZNTL

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 40.56M26.86M
Operating items
Research & Development 46.11M43.83M42.18M40.62M48.58M42.68M46.77M51.56M49.59M48.39M36.82M32.97M27.25M27.61M22.95M
Selling, General & Administrative 11.77M19.64M12.01M11.14M16.37M15.66M15.95M16.36M15.74M16.76M14.61M40.01M10.58M8.45M10.78M
Restructuring Costs 7.80M
Other Operating Expenses 45.57M3.74M-0.00M
Operating Expenses 57.88M63.46M54.19M51.75M64.95M103.92M62.72M67.92M65.33M65.15M51.43M76.71M45.62M36.06M33.73M
Operating Income -57.88M-63.46M-54.19M-51.75M-64.95M-103.92M-62.72M-67.92M-24.77M-65.15M-51.43M-49.85M-45.62M-36.06M-33.73M
EBIT -57.88M-63.46M-54.19M-51.75M-64.95M-103.92M-62.72M-67.92M-24.77M-65.15M-51.43M-49.85M-45.62M-36.06M-33.73M
Non-operating items
Interest & Investment Income 0.43M0.42M1.91M3.23M4.11M4.45M7.21M6.85M34.95M-22.86M11.25M2.17M-2.66M9.18M7.04M
Net income details
EBT -57.45M-63.04M-52.29M-48.52M-60.84M-99.47M-55.51M-61.07M10.18M-88.01M-40.19M-47.68M-48.28M-26.87M-26.69M
Tax Provisions 0.03M0.02M-0.16M-0.36M0.11M-0.60M0.03M-0.14M0.14M0.27M-0.03M-0.20M
Profit After Tax -59.24M-68.39M-54.50M-54.98M-63.26M-112.56M-55.54M-60.94M10.07M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M
Equity Income -1.75M-5.34M-2.37M-6.82M-2.31M-13.70M
Net Income - Minority -0.22M-0.18M-0.14M-0.13M-0.11M
Income from Non-Controlling Interests -0.16M-0.04M-0.10M-0.01M-0.04M-0.04M-0.01M-0.02M-0.03M
Income from Continuing Operations -57.49M-63.05M-52.13M-48.16M-60.95M-98.86M-55.54M-60.94M10.04M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M
Consolidated Net Income -57.49M-63.05M-52.13M-48.16M-60.95M-98.86M-55.54M-60.94M10.04M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M
Income towards Parent Company -57.49M-63.05M-52.13M-48.38M-61.13M-99.00M-55.67M-61.05M10.04M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M
Net Income towards Common Stockholders -57.49M-63.05M-52.13M-48.38M-61.13M-99.00M-55.67M-61.05M10.04M-88.28M-40.16M-47.47M-48.28M-26.87M-26.69M
Additional items
EPS (Basic) -1.31-1.34-0.96-0.92-1.07-1.85-0.79-0.830.14-1.24-0.56-0.66-0.67-0.37-0.37
EPS (Weighted Average and Diluted) -1.31-1.34-0.96-0.92-1.07-1.85-0.79-0.830.14-1.24-0.56-0.66-0.67-0.37-0.37
Shares Outstanding (Weighted Average) 46.63M46.63M56.98M57.07M59.42M59.48M70.61M70.96M70.96M71.01M71.11M71.81M71.95M72.14M72.14M
Shares Outstanding (Diluted Average) 45.24M51.12M56.81M52.86M59.28M60.79M70.61M65.41M71.19M71.04M71.11M71.08M71.68M71.99M72.14M
EBITDA -57.88M-63.46M-54.19M-51.75M-64.95M-103.92M-62.72M-67.92M-24.77M-65.15M-51.43M-49.85M-45.62M-36.06M-33.73M
Shares Outstanding 45.58M56.97M57.00M59.28M59.44M70.60M70.64M70.77M71.01M
Tax Rate 0.300.740.610.221.400.070.43